Disclosure of payments made to HCPs in Hong Kong

Cooperation between pharmaceutical companies, regulators, Healthcare Professionals (HCPs) and patients, is essential for the sustainable improvement of healthcare. These relationships have helped deliver numerous innovative medicines and changed the way many diseases impact on our lives. HCPs have always been and will remain valuable partners for GSK.

We are committed to working with these HCPs with the highest level of transparency and ethical standards. We provide a range of support for them across Hong Kong. We acknowledge the importance of increased transparency of these transfers of value and of putting the patient at the centre of every decision we take.

As part of our continued commitment to transparency, we are committed to increasing our level of disclosure by proactively disclosing all GSK payments made at an individual level to HCPs (where applicable) on an annual basis from 2019 activities onwards.

Our payments to HCPs include the provision of services such as giving a lecture, attending/ supporting educational meetings, providing advice as a member of an Advisory Board or as a Consultant, as well as travel and accommodation expenses associated with those services.

Kindly follow the steps outlined below to view payments we have made to HCPs in Hong Kong.

1. Select a Year
2. Input Full name of the desired HCP.
3. Click Search